Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01153204Phase 4Completed
Phase 4, randomised, single-blind trial of sildenafil in psychogenic erectile dysfunction (PED) (3 arms), sponsored by Federal University of São Paulo. Primary endpoint: Satisfaction with the treatment at 9 months. Status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01153204.